RxDoctor Payments Data

Guillermo Guzman Trevino, MD

Obstetrics & Gynecology · Nampa, IDNPI 1881828010

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,807 of the $15,057 with a category attached, or 85.1%. Hologic Sales And Service, LLC accounts for 71.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $8,360 and has fallen 98.7% since, to $109 in 2024. Among obstetrics & gynecology clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,057in general payments, 2019–2025

Across 27 payments — averaging $557.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hologic Sales And Service, LLC$11K
  • Gen-probe, Inc.$4K
  • Intuitive Surgical$76
  • AbbVie$74
  • Astellas Pharma US Inc$34
  • Bayer$31
  • plus $62 from 3 others

What the payments were for

  • Consulting fees$12,80785%
  • Speaking & faculty fees$1,60011%
  • Food & beverage$6504%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,057 in reported general payments places this provider in the 95th percentile of 166 obstetrics & gynecology providers in Idaho.

See all obstetrics & gynecology providers in Idaho

Medicare billing

Part B allowed, 2024
$4,743
Medicare patients
28
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol21$2,332
ElinestNorgestrel-Ethinyl Estradiol17$271

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Nampa

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →